Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Steffel

Showing results (91-100 of 204) with videos related to

Pageof 21
Sort By:
Heart (British Cardiac Society)|January 29, 2011
Electrocardiographic changes in early recognition of Fabry diseaseMehdi Namdar, Jan Steffel, Mile Vidovic, et al.
European Heart Journal|March 18, 2010
Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodellingGeorg Fröhlich, Jan Steffel, David Hürlimann, et al.
Heart Rhythm|May 25, 2010
Implantable cardioverter-defibrillator and cardiac resynchronization therapy in patients with left ventricular noncompactionRichard Kobza, Jan Steffel, Paul Erne, et al.
European Heart Journal|March 29, 2012
The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarization: data from a randomized controlled trialValentina A Rossi, Anne-Christin Stoewhas, Giovanni Camen, et al.
Pacing and Clinical Electrophysiology : PACE|May 30, 2013
Generator pocket adhesions of cardiac leads: classification and correlation with transvenous lead extraction resultsHector Rodriguez Cetina Biefer, David Hürlimann, Jürg Grünenfelder, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 11, 2014
Outcome of super-responders to cardiac resynchronization therapy defined by endpoint-derived parameters of left ventricular remodeling: a two-center retrospective studyDavid Hürlimann, Susann Schmidt, Burkhardt Seifert, et al.
European Heart Journal|April 25, 2018
Stroke prevention in atrial fibrillation: re-defining 'real-world data' within the broader data universeAlexander C Fanaroff, Jan Steffel, John H Alexander, et al.
Acta Cardiologica|November 17, 2015
Does implantation technique influence lead failure?Tomas Holubec, Gianluca Ursprung, Felix Schönrath, et al.
Atherosclerosis|October 9, 2007
Cyclophilin A differentially activates monocytes and endothelial cells: role of purity, activity, and endotoxin contamination in commercial preparationsSravan K Payeli, Cordelia Schiene-Fischer, Jan Steffel, et al.
Journal of Vascular Research|February 1, 2007
Different migration of vascular smooth muscle cells from human coronary artery bypass vessels. Role of Rho/ROCK pathwaySabine Weiss, Karin Frischknecht, Helen Greutert, et al.
Pageof 21

Showing results (91-100 of 204) with videos related to

Sort By:
Pageof 21
Heart (British Cardiac Society)|January 29, 2011
Electrocardiographic changes in early recognition of Fabry diseaseMehdi Namdar, Jan Steffel, Mile Vidovic, et al.
European Heart Journal|March 18, 2010
Upgrading to resynchronization therapy after chronic right ventricular pacing improves left ventricular remodellingGeorg Fröhlich, Jan Steffel, David Hürlimann, et al.
Heart Rhythm|May 25, 2010
Implantable cardioverter-defibrillator and cardiac resynchronization therapy in patients with left ventricular noncompactionRichard Kobza, Jan Steffel, Paul Erne, et al.
European Heart Journal|March 29, 2012
The effects of continuous positive airway pressure therapy withdrawal on cardiac repolarization: data from a randomized controlled trialValentina A Rossi, Anne-Christin Stoewhas, Giovanni Camen, et al.
Pacing and Clinical Electrophysiology : PACE|May 30, 2013
Generator pocket adhesions of cardiac leads: classification and correlation with transvenous lead extraction resultsHector Rodriguez Cetina Biefer, David Hürlimann, Jürg Grünenfelder, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 11, 2014
Outcome of super-responders to cardiac resynchronization therapy defined by endpoint-derived parameters of left ventricular remodeling: a two-center retrospective studyDavid Hürlimann, Susann Schmidt, Burkhardt Seifert, et al.
European Heart Journal|April 25, 2018
Stroke prevention in atrial fibrillation: re-defining 'real-world data' within the broader data universeAlexander C Fanaroff, Jan Steffel, John H Alexander, et al.
Acta Cardiologica|November 17, 2015
Does implantation technique influence lead failure?Tomas Holubec, Gianluca Ursprung, Felix Schönrath, et al.
Atherosclerosis|October 9, 2007
Cyclophilin A differentially activates monocytes and endothelial cells: role of purity, activity, and endotoxin contamination in commercial preparationsSravan K Payeli, Cordelia Schiene-Fischer, Jan Steffel, et al.
Journal of Vascular Research|February 1, 2007
Different migration of vascular smooth muscle cells from human coronary artery bypass vessels. Role of Rho/ROCK pathwaySabine Weiss, Karin Frischknecht, Helen Greutert, et al.
Pageof 21